Are <i>ENT1</i>/ENT1, <i>NOTCH3,</i> and miR-21 Reliable Prognostic Biomarkers in Patients with Resected Pancreatic Adenocarcinoma Treated with Adjuvant Gemcitabine Monotherapy?

Are <i>ENT1</i>/ENT1, <i>NOTCH3,</i> and miR-21 Reliable Prognostic Biomarkers in Patients with Resected Pancreatic Adenocarcinoma Treated with Adjuvant Gemcitabine Monotherapy?

Evidence on equilibrative nucleoside transporter 1 (ENT1) and microRNA-21 (miR‑21) is not yet sufficiently convincing to consider them as prognostic biomarkers for patients with pancreatic ductal adenocarcinoma (PDAC). Here, we investigated the prognostic value of <i>ENT1</i>/ENT1, miR-2...

Full description

Bibliographic Details
Main Authors: Lucie Jiraskova, Ales Ryska, Erik Jurjen Duintjer Tebbens, Helena Hornychova, Filip Cecka, Frantisek Staud, Lukas Cerveny
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Cancers
Subjects:
adjuvant gemcitabine monotherapy
equilibrative nucleoside transporter 1
neurogenic locus homolog protein 3
mir-21
resected pancreatic ductal adenocarcinoma
prognostic biomarker
Online Access:https://www.mdpi.com/2072-6694/11/11/1621

Internet

https://www.mdpi.com/2072-6694/11/11/1621

Similar Items